Table 3

Summary of the genome-wide significant and suggestive SNPs for hip OA and their estimated heritability

ReferenceSNPGeneOREAFλsExpected GV explained (%)
Genome wide significant findings (p<5×10−8) 
 This studyrs6094710NCOA31.280.041.00290.46
 arcOGEN6rs6976GLT8D11.120.371.00310.60
 arcOGEN6rs11177GNL31.120.381.00310.60
 arcOGEN6rs4836732ASTN21.200.471.00831.66
 arcOGEN6rs9350591FILIP1;SENP61.180.111.00300.54
 arcOGEN6rs10492367KLHDC5;PTHLH1.140.191.00290.53
 3arcOGEN6rs835487CHST111.130.341.00340.67
 TreatOA12rs12982744DOT1L1.170.381.00601.16
Suggestive findings (5×10−6<p<5×10−8) 
 This studyrs5009270IFRD11.100.301.00190.38
 This studyrs3757837CAMK2B1.270.061.00400.64
 arcOGEN6rs12107036TP631.210.521.00901.81
 arcOGEN6rs8044769FTO1.110.501.00270.54
 arcOGEN6rs10948172SUPT3H;CDC5L1.140.291.00370.71
  • EAF, effect allele frequency; GV, genetic variance; OA, osteoarthritis.